ag 1879 has been researched along with Experimental Mammary Neoplasms in 1 studies
3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tabariès, S | 1 |
| Annis, MG | 1 |
| Hsu, BE | 1 |
| Tam, CE | 1 |
| Savage, P | 1 |
| Park, M | 1 |
| Siegel, PM | 1 |
1 other study available for ag 1879 and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis.
Topics: Animals; Apoptosis; Carcinoma; Cell Line, Tumor; Claudins; Dasatinib; Female; Gene Expression Regula | 2015 |